| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |